New Reverse Sum Revan Indices for Anti-Filovirus Drugs
Author Information
Author(s): Tamilarasi W., Balamurugan B. J.
Primary Institution: Vellore Institute of Technology, Chennai, Tamil Nadu, India
Hypothesis
The study introduces new reverse sum Revan degree-based indices to explore the physicochemical and pharmacokinetic properties of anti-filovirus drugs.
Conclusion
The findings reveal a strong correlation between the proposed indices and the properties of anti-filovirus drugs, offering valuable insights for drug analysis.
Supporting Evidence
- The new indices showed strong correlations with the physicochemical and pharmacokinetic properties of anti-filovirus drugs.
- Multilinear regression analysis indicated that the new indices provide better predictive accuracy compared to existing indices.
- The study suggests that theoretical analyses can help predict drug properties without experimental testing.
Takeaway
This study created new ways to measure how certain drugs work against viruses like Ebola and Marburg, helping scientists understand their properties better.
Methodology
The study used multilinear regression to analyze the relationship between the new indices and the properties of anti-filovirus drugs.
Limitations
The analysis depends on available physicochemical and pharmacokinetic data, which might not fully reflect real-life drug interactions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website